Literature DB >> 20075172

Response: Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy persons.

Kanji Uchida, Brenna Carey, Takuji Suzuki, Koh Nakata, Bruce Trapnell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20075172      PMCID： PMC2808163          DOI： 10.1182/blood-2009-11-246041

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Jeffrey J Presneill; Koh Nakata; Yoshikazu Inoue; John F Seymour
Journal:  Clin Chest Med       Date:  2004-09       Impact factor: 2.878

2.  GM-CSF autoantibodies in pulmonary alveolar proteinosis.

Authors:  Klaus Bendtzen; Morten Svenson; Morten B Hansen
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

3.  Anti-cytokine autoantibodies are ubiquitous in healthy individuals.

Authors:  Masato Watanabe; Kanji Uchida; Kazuhide Nakagaki; Hiroko Kanazawa; Bruce C Trapnell; Yoshihiko Hoshino; Hiroshi Kagamu; Hirohisa Yoshizawa; Naoto Keicho; Hajime Goto; Koh Nakata
Journal:  FEBS Lett       Date:  2007-04-24       Impact factor: 4.124

4.  Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents.

Authors:  J P Bouvet; D Stahl; S Rose; C P Quan; M D Kazatchkine; S V Kaveri
Journal:  J Autoimmun       Date:  2001-03       Impact factor: 7.094

5.  Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy.

Authors:  M Wadhwa; C Bird; J Fagerberg; R Gaines-Das; P Ragnhammar; H Mellstedt; R Thorpe
Journal:  Clin Exp Immunol       Date:  1996-05       Impact factor: 4.330

6.  High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

Authors:  Kanji Uchida; Koh Nakata; Bruce C Trapnell; Takahiro Terakawa; Emi Hamano; Ayako Mikami; Ikumi Matsushita; John F Seymour; Masayoshi Oh-Eda; Ikuo Ishige; Yoshinobu Eishi; Takayuki Kitamura; Yoshitsugu Yamada; Kazuo Hanaoka; Naoto Keicho
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

7.  Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.

Authors:  Isabelle St-Amour; André Laroche; Renée Bazin; Réal Lemieux
Journal:  Clin Immunol       Date:  2009-07-15       Impact factor: 3.969

8.  Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors:  Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

9.  Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.

Authors:  Kanji Uchida; Koh Nakata; Takuji Suzuki; Maurizio Luisetti; Masato Watanabe; Diana E Koch; Carrie A Stevens; David C Beck; Lee A Denson; Brenna C Carey; Naoto Keicho; Jeffrey P Krischer; Yoshitsugu Yamada; Bruce C Trapnell
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

10.  GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

Authors:  Kanji Uchida; David C Beck; Takashi Yamamoto; Pierre-Yves Berclaz; Shuichi Abe; Margaret K Staudt; Brenna C Carey; Marie-Dominique Filippi; Susan E Wert; Lee A Denson; Jonathan T Puchalski; Diane M Hauck; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.